Skip to content
Medical Health Aged Care

New mobile app helps people track their methamphetamine use and reduce drug-related harms

NDARC/NCCRED/UNSW 2 mins read

Researchers at the National Centre for Clinical Research on Emerging Drugs (NCCRED) have launched the S-Check app to encourage people who use methamphetamine to seek help and treatment earlier.

S-Check is a self-administered smartphone app for people to track their methamphetamine use, monitor the impact of the drug on their health and wellbeing, and get tips and support for any health issues.

Based on the Stimulant Check-Up (S-Check) service model at St Vincent’s Hospital Sydney (SVHS), the app is aimed at engaging people who have not previously accessed traditional modes of treatment to reduce harms and to encourage them to seek treatment before problematic methamphetamine use begins or becomes entrenched.

The team at NCCRED, which is based at SVHS and the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney, said they hoped to address the substantial delays in treatment seeking that is typical among individuals with problematic methamphetamine use.

“The time between problems arising due to methamphetamine use and seeking treatment can be up to 10 years, and existing treatment options for people who use methamphetamine are limited,” said NCCRED Clinical Research Lead, Dr Krista Siefried.

“Apps like S-Check provide an option for people who are curious about their use or looking for resources while they wait for treatment.”

S-Check allows individuals to complete self-assessments to understand the impact of methamphetamine use on their broader health, such as their psychological wellbeing and sexual health.

Information collected in the app can also be shared with an individual’s doctor or other healthcare provider for a more tailored health assessment.

The launch of S-Check follows promising results from a 28-day clinical trial that included 560 Australian adults who reported methamphetamine use at least once a month, half of whom had immediate access to the app.

“In a randomised trial this app supported people in exploring their methamphetamine use and its impacts on their sexual, psychological and physical health,” said Dr Siefried.

“People who had immediate access were more likely to seek out professional help in the following 28 days than those who were randomised to wait.”

The 2023 study showed that compared to the control group, almost twice as many participants with immediate access to S-Check sought professional help by day 28.

Furthermore, among those not seeking help at baseline, each minute spent using the app increased the likelihood of seeking professional help by 8% by the end of the trial.

S-Check can be downloaded for free from the iOS and Android app stores.

-ENDS-


Contact details:

Dr Krista Siefried is available for media interviews.

Media contact: 0401 713 850 | ndarc.media@unsw.edu.au

For reference: When reporting on drugs and alcohol, we encourage consultation of the Mindframe guidelines on Communicating about alcohol and other drugs’ and ‘Communicating about suicide, and the ‘Language Matters guide published by the NSW Users and AIDS Association. 

We also encourage inclusion of the following helpline information in all reporting:

People can access free and confidential advice about alcohol and other drugs by calling the National Alcohol and Other Drug Hotline on 1800 250 015.

More from this category

  • Medical Health Aged Care
  • 19/01/2025
  • 10:16
Royal Australian College of GPs

GPs welcome free RSV vaccine for pregnant women

The Royal Australian College of GPs (RACGP) has applauded the Federal Government announcing a free RSV vaccine to help protect newborns available for pregnant women. The Government’s $174.5 million investment will ensure the vaccine can be offered free of charge as part of the National Immunisation Program from 3 February this year. The respiratory syncytial virus causes cold-like symptoms for many people, but the young are very vulnerable to its effects. Around 12,000 babies are admitted to hospital with severe RSV each year, and the virus is the most common cause of hospitalisation for infants in Australia. College President, Dr…

  • Medical Health Aged Care
  • 17/01/2025
  • 10:12
Dementia Australia

Country music singer Adam Harvey appointed Dementia Australia Ambassador in honour of his mother

Dementia Australia welcomes renowned country music singer and songwriter Adam Harvey as its newest Ambassador, coinciding with his headline performances at the Tamworth Country Music Festival. Adam, a nine-time Golden Guitar Award winner, has a deeply personal connection to dementia. His mother’s diagnosis inspired him to write his heartfelt song, Remember Me, which he will perform this weekend. Through his music and platform, Adam hopes to bring greater awareness to dementia and its impact on families across Australia. “My mum’s journey with dementia has been deeply challenging for my family, but it has also shown me the importance of understanding,…

  • Contains:
  • Medical Health Aged Care, Sport Recreation
  • 17/01/2025
  • 08:40
Breast Cancer Network Australia

World-First Data: Supervised exercise program for people with incurable breast cancer reveals significant health and economic benefits.

17January, 2025 A world-first study has revealed that two hours of supervised exercise per week significantly benefits people with metastatic breast cancer, improving quality of life while reducing healthcare costs. The PREFERABLE-EFFECT trial, involving 357 participants worldwide, including 135 Australians, is the most extensive exercise study conducted for this population. Participants completed a nine-month program of supervised aerobic, resistance, and balance exercises twice a week, compared to those following general activity advice. Participants in the supervised exercise program experienced significant improvements in quality of life, with reductions in debilitating symptoms such as fatigue, pain, and emotional distress, enabling them to…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.